oncology quiz with answers
DESCRIPTION
TRANSCRIPT
![Page 1: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/1.jpg)
IASO Quiz 2013
Instituted byDr Panda and Dr K Gopinath
![Page 2: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/2.jpg)
Identify this cancer survivor
![Page 3: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/3.jpg)
Identify this cancer survivor
Lance Armstrong
![Page 4: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/4.jpg)
Following the 2012 USPSTF recommendation against PSA screening in
all men, which group saw a decrease in screening frequency by PCPs?
A. Men between 40-49yrsB. Men above 79 yrsC. Patients with previous highest PSA
<2.49ng/mlD. All the above
![Page 5: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/5.jpg)
Following the 2012 USPSTF recommendation against PSA screening in
all men, which group saw a decrease in screening frequency by PCPs?
A. Men between 40-49yrsB. Men above 79 yrsC. Patients with previous highest PSA
<2.49ng/mlD. All the aboveCohn JA, et al. Urol Oncol. 2013 Aug 1. [Epub ahead of print]
![Page 6: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/6.jpg)
PSA screening is likely to reduce mortality due to prostate cancer. However the conclusion is likely to be affected by
A. Selection BiasB. Lead and length BiasC. Exposure and measurement issuesD. All the above
![Page 7: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/7.jpg)
PSA screening is likely to reduce mortality due to prostate cancer. However the conclusion is likely to be affected by
A. Selection BiasB. Lead and length BiasC. Exposure and measurement issuesD. All the above
![Page 8: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/8.jpg)
Urethral Cancer which invades bladder neck, single inguinal node 3cm is staged
A. T4N2M0B. T4N1M0C. T2N1M0D. T3N2M0
![Page 9: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/9.jpg)
Urethral Cancer which invades bladder neck, single inguinal node 3cm is staged
A. T4N2M0B. T4N1M0C. T2N1M0D. T3N2M0
![Page 10: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/10.jpg)
Micromets play an important role in the natural progression of urothelial cancer.
What percentage of organ confined node negative bladder cancers recur following
cystectomy?A. 25%B. 5%C. 40%D. 60%
![Page 11: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/11.jpg)
Micromets play an important role in the natural progression of urothelial cancer.
What percentage of organ confined node negative bladder cancers recur following
cystectomy?A. 25%B. 5%C. 40%D. 60%Bladder cancer: Diagnosis Therapeutics and Management.
Ed.Cheryl T Lee and David P Wood. 2010 page 89.
![Page 12: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/12.jpg)
BCG for superficial bladder cancer can be potentiated for additional benefit if combined with which of the following:
A. Mitomycin CB. Interferon C. EpirubicinD. None of the above
![Page 13: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/13.jpg)
BCG for superficial bladder cancer can be potentiated for additional benefit if combined with which of the following:
A. Mitomycin CB. Interferon C. EpirubicinD. None of the aboveZhu S et al. BMC cancer 2013,Jul 5; 13: 322. Pooled results of a recent meta-
analysis of 21 RCT and 9 comparative studiess showed a better recurrence free survival for BCG+Epirubicin at the cost of an increase in toxicity.
![Page 14: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/14.jpg)
Intravesical BCG for non muscle invasive bladder cancer for older
patients
A. Improves Overall SurvivalB. Improves Bladder cancer specific survivalC. Improves Os but not BCSSD. Improves OS and BCSS
![Page 15: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/15.jpg)
Intravesical BCG for non muscle invasive bladder cancer for older
patients
A. Improves Overall SurvivalB. Improves Bladder cancer specific survivalC. Improves Os but not BCSSD. Improves OS and BCSSSpencer BA, et al. J Oncol Pract. 2013;9(2):92-98.
![Page 16: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/16.jpg)
Name the medicinal Plant/tree/seeds
Supposed to enhance memory
![Page 17: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/17.jpg)
Name the medicinal Plant/tree/seeds
Supposed to enhance memoryGinko biloba
![Page 18: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/18.jpg)
The correct statement below is:
A. HPV vaccination is highly effective against development of cervical dysplasia
B. HPV vaccination is highly effective against development of anal and cervical dysplasia
C. HPV vaccination is highly effective against development of cervical, anal and oral dysplasia
![Page 19: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/19.jpg)
The correct statement below is:
A. HPV vaccination is highly effective against development of cervical dysplasia
B. HPV vaccination is highly effective against development of anal and cervical dysplasia
C. HPV vaccination is highly effective against development of cervical, anal and oral dysplasiaPalefsky et al. NEJM 2011;365(17):1576
![Page 20: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/20.jpg)
Vit D receptor Bsm1 polymorphism may represent a risk factor for
_______ women with ovarian cancer
A. AsianB. North AmericanC. EuropeanD. South American
![Page 21: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/21.jpg)
Vit D receptor Bsm1 polymorphism may represent a risk factor for
_______ women with ovarian cancer
A. AsianB. North AmericanC. EuropeanD. South AmericanVDR Bsm1 polymorphism is generally no associated with Ovarian
cancer risk. However a subgroup analysis of the study by Qin X et al ( Int J Gyn Cancer 2013. 23(7): 1178-83) showed european population to be at risk.
![Page 22: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/22.jpg)
Which is not a paraneoplastic syndrome associated with Lung Cancer
A. Horner’ syndromeB. Lambert-Eaton SyndromeC. Sweet’s SyndromeD. Dermatomyositis
![Page 23: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/23.jpg)
Which is not a paraneoplastic syndrome associated with Lung Cancer
A. Horner’ syndromeB. Lambert-Eaton SyndromeC. Sweet’s SyndromeD. Dermatomyositis
The syndrome was first described in 1964 by Dr. Robert D Sweet. It was also known as Gomm-Button disease in honour of the first two patients diagnosed. It is characterized by erythematous well defined cutaneous papules associates with fever and is associated with haematologic malignancies like leukaemia, Rheumatoid Arthritis, IBD, Behcets Syndrome.
![Page 24: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/24.jpg)
The dividing line to discriminate 2R and 4R from 2L and 4L when
staging Lung Cancer is
A. Midline of tracheaB. Right Border of TracheaC. Left border of Trachea
![Page 25: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/25.jpg)
The dividing line to discriminate 2R and 4R from 2L and 4L when
staging Lung Cancer is
A. Midline of tracheaB. Right Border of TracheaC. Left border of Trachea
![Page 26: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/26.jpg)
Nodal station not amenable to be assessed by standard cervical
mediastinoscopy for staging lung cancer
A. Station 3B. Station 6C. Station 7D. Station 5
![Page 27: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/27.jpg)
Nodal station not amenable to be assessed by standard cervical
mediastinoscopy for staging lung cancer
A. Station 3B. Station 6C. Station 7D. Station 5
![Page 28: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/28.jpg)
This 62 yr old pathologist who has undergone complete resection for a lung cancer is staged
pT2 N0 M0. He asks you regarding adjuvant therapy with Geftinib. Your answer is--
A. Yes it is beneficial in stage Ib, II and IIIa lung cancer
B. Adjuvant Geftinib benefits only wild type EGFRC. Adjuvant Geftinib benefits only mutant EGFRD. No benefit of Adjuvant Geftinib
![Page 29: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/29.jpg)
This 62 yr old pathologist who has undergone complete resection for a lung cancer is staged
pT2 N0 M0. He asks you regarding adjuvant therapy with Geftinib. Your answer is--
A. Yes it is beneficial in stage Ib, II and IIIa lung cancer
B. Adjuvant Geftinib benefits only wild type EGFRC. Adjuvant Geftinib benefits only mutant EGFRD. No benefit of Adjuvant Geftinib
Gross GD et al. JCO 2013; 31(17) 3320-26. Trial was stopped mid way due to lack of benefit
![Page 30: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/30.jpg)
Not associated with pleural Mesothelioma
A. SV 40 infectionB. Erionite exposureC. Thorium Dioxide therapyD. HPV Infection
![Page 31: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/31.jpg)
Not associated with pleural Mesothelioma
A. SV 40 infectionB. Erionite exposureC. Thorium Dioxide therapyD. HPV Infection
Lung Cancer : Prevention, Management and Emerging Therapies. David J Stewart Ed. 2010; page 437.
![Page 32: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/32.jpg)
OCP and HRT use are associated with increase in breast cancer and
Lung cancerA. TrueB. False
![Page 33: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/33.jpg)
OCP and HRT use are associated with increase in breast cancer and
Lung cancerA. TrueB. False
ILCC pooled analysis of 6 case control studies ( 1961 cases and 2609 controls) found a reduced risk of lung ca in HRT (Adeno and Small Cell) and OCP (Squamous CA)users. There was no dose response relationship with years of OCP/HRT.Pesatori AC et al. Br J Cancer 2013; 109(7) 1954-64.
![Page 34: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/34.jpg)
Which of the following is an inhibitor of PDGFR
A. DasatinibB. VandetanibC. SorafenibD. Imatinib
![Page 35: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/35.jpg)
Which of the following is an inhibitor of PDGFR
A. DasatinibB. Vandetanib - VEGFR-2C. Sorafenib - DS DNA break repairD. Imatinib - Bcl-2
![Page 36: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/36.jpg)
Name the book by this Ethiopia born physician which talks of liver transplantation
A. My JourneyB. Another lifeC. Cutting for StoneD. Emperor’s Malady
![Page 37: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/37.jpg)
Name the book by this Ethiopia born physician which talks of liver transplantation
A. My JourneyB. Another lifeC. Cutting for StoneD. Emperor’s Malady
![Page 38: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/38.jpg)
Does higher UV radiation exposure of pregnant women reduce incidence of some
childhood cancers
A. Yes B. No
![Page 39: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/39.jpg)
Does higher UV radiation exposure of pregnant women reduce incidence of some
childhood cancers
A. Yes B. NoLombardi C et al. cancer Epidemiology, Biomarkers and Prevention 2013;22(6): 1118-1128
• Results: For cases with UVR exposure of 5,111 Watt-hours/m2 or above, we estimated a reduction in odds of developing acute lymphoblastic leukemia (OR: 0.89, 95% CI: 0.81–0.99), hepatoblastoma (OR: 0.69, 95% CI: 0.48–1.00), and non-Hodgkin's lymphoma (OR: 0.71, 95% CI: 0.50–1.02) adjusting for mother's age, mother's race, and child's year of birth. We also observed a small increase in odds for intracranial/intraspinal embryonal tumors (OR: 1.29, 95% CI: 1.01–1.65).
• Conclusions: Our findings suggest that UVR during pregnancy may decrease the odds of some childhood cancers. Future studies should explore additional factors that may be correlated with UVR exposure and possibly include biomarkers of immune function and vitamin D.
![Page 40: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/40.jpg)
Melanoma subtype which is characterized by bland fibroblastic
appearance and often mimics a scar-
A. DesmoplasticB. Acral LetigenousC. NodularD. Lentigo maligna
![Page 41: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/41.jpg)
Melanoma subtype which is characterized by bland fibroblastic
appearance and often mimics a scar-
A. DesmoplasticB. Acral LetigenousC. NodularD. Lentigo maligna
DM are strongly and homogeneously positive for S-100 protein but are often negative or only focally positive for melanocyte differentiation antigens such as tyrosinase, gp100, Melan-A, and microphthalmia transcription factor. DM differs from conventional melanoma in its clinical course. It is associated with a higher tendency for local recurrence, but metastases to regional lymph nodes are less common.
Wood BA. Pathology 2013; 45(5): 453-463
![Page 42: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/42.jpg)
Who is this medical inventor
A. Dr Eric Blom. B. Dr Robert EstherC. Dr Douglas J. Schwartzentruber
![Page 43: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/43.jpg)
Who is this medical inventor
A. Dr Eric Blom. Inventor of the Blom Singer Prosthesis for laryngectomee patients
B. Dr Robert EstherC. Dr Douglas J. Schwartzentruber
Melanoma Vaccine
![Page 44: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/44.jpg)
Pet scan is often advised for follow-up in patients treated for HNSCC. Which of the following is correct statement
A. PET scan does not obviate the need for standard radiology
B. Two negative PET scans at 6 month intervals obviates the need for additional radiology
C. Single negative PET scan obviates the need for additional radiology
![Page 45: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/45.jpg)
Pet scan is often advised for follow-up in patients treated for HNSCC. Which of the following is correct statement
A. PET scan does not obviate the need for standard radiology
B. Two negative PET scans at 6 month intervals obviates the need for additional radiology
C. Single negative PET scan obviates the need for additional radiologyMc Dermott et al. AJNR 2013; 34(8): 1631-36The NPV of 2 negative PET scans at 6 month intervals was 98% compared to 91% for a single negative PET scan
![Page 46: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/46.jpg)
Most likely site of an asymptomatic recurrence of H&N cancer is
A. ThoracicB. AbdominalC. Regional nodalD. Primary site
![Page 47: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/47.jpg)
Most likely site of an asymptomatic recurrence of H&N cancer is
A. ThoracicB. AbdominalC. Regional nodalD. Primary siteDunsky KA et al. Laryngoscope 2013; 123(9): 2161-64
![Page 48: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/48.jpg)
H&N Liposarcomas are likely to be
A. Commonly deep and have poor outcomeB. DFS and OS poorer than conventional
liposarcomsC. Low grade and early stageD. Deep seated but low grade and stage
![Page 49: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/49.jpg)
H&N Liposarcomas are likely to be
A. Commonly deep and have poor outcomeB. DFS and OS poorer than conventional
liposarcomsC. Low grade and early stageD. Deep seated but low grade and stageGerry D et al. Head and Neck 2013; Jun 01 Epub
![Page 50: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/50.jpg)
Stage IVa H&N Melanoma is
A. T1 N2 M0B. T3 N1 M0C. T4b N0 M0D. T3 N2 M0
![Page 51: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/51.jpg)
Stage IVa H&N Melanoma is
A. T1 N2 M0B. T3 N1 M0C. T4b N0 M0D. T3 N2 M0
![Page 52: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/52.jpg)
One of the following is not implicated in the development of carcinoma of
the larynx.
A. TobaccoB. Leather DustC. Strong Inorganic MistsD. Asbestos Dust and Fibre
.
![Page 53: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/53.jpg)
One of the following is not implicated in the development of carcinoma of
the larynx.
A. TobaccoB. Leather DustC. Strong Inorganic MistsD. Asbestos Dust and Fibre
Head and Neck CA. Current Perspectives and Challenges. Ed James A Radosevich. 2013: page 58. The other 3 have a strong association. Others with limited evidence are HPV 16,18, Sulfur Mustard, Rubber production, secondary tobacco smoke. Less than 1% are due to alcohol alone.
![Page 54: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/54.jpg)
The journey of this physician’s discovery and clinical application was captured in a
Hollywood movie in 2008 starring Harry Connick -
A. Living ProofB. A Gift of LifeC. Nude RatsD. The Lonely Road
![Page 55: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/55.jpg)
The journey of this physician’s discovery and clinical application was captured in a
Hollywood movie in 2008 starring Harry Connick -
A. Living ProofB. A Gift of LifeC. Nude RatsD. The Lonely Road
![Page 56: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/56.jpg)
Triple negative breast cancers typically demonstrate
A. Chemotherapy sensitivityB. Chemotherapy insensitivityC. Sensitive to only cisplatinD. Chemotherapy sensitivity followed shorter
durable response
![Page 57: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/57.jpg)
Triple negative breast cancers typically demonstrate
A. Chemotherapy sensitivityB. Chemotherapy insensitivityC. Sensitive to only cisplatinD. Chemotherapy sensitivity followed shorter
durable response
![Page 58: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/58.jpg)
The residual tumour excised at surgery following neoadjuvant therapy with
Trastuzumab and Chemotherapy is likely to have --
A. Retained Her2 expressionB. Gained Her2 point mutationsC. Lost Her2 expressionD. Lost Her2 point mutations
![Page 59: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/59.jpg)
The residual tumour excised at surgery following neoadjuvant therapy with
Trastuzumab and Chemotherapy is likely to have --
A. Retained Her2 expressionB. Gained Her2 point mutationsC. Lost Her2 expressionD. Lost Her2 point mutations
• In a study of 167 HER2-positive breast cancer patients, participants who received neoadjuvant chemotherapy without anti-HER2 treatment were more likely to demonstrate HER2 loss within their residual disease (40% vs 14.7%, P=0.019). Additionally, HER2 loss demonstrated a trend towards higher risk of relapse (HR 2.41, P=0.063). The pCR is confirmed as a powerful predictor of long-term outcome. The rate of HER2 loss is higher in patients receiving neoadjuvant CT without anti-HER2 agents. HER2 status on residual disease after preoperative therapy can be helpful in selecting patients at different risk of relapse, to be included in prospective trial exploring further adjuvant therapy.Guarneri V, et al. Ann Oncol. 2013 Sep 7. [Epub ahead of print]
![Page 60: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/60.jpg)
Which of the following predicts the possibility of recurrence in node
negative breast cancerA. Lymphovascular invasionB. Age of patientC. Perineural spreadD. Adjuvant radiotherapy
![Page 61: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/61.jpg)
Which of the following predicts the possibility of recurrence in node
negative breast cancerA. Lymphovascular invasionB. Age of patientC. Perineural spreadD. Adjuvant radiotherapy
In a study of 716 patients with node-negative breast cancer, 47 ultimately recurred during 47 months of median follow-up. Lymphovascular invasion (HR 4.6) and Nottingham grade 3 (HR 4.99) tumors were independent risk factors associated with an increased risk of recurrence. Adjuvant radiotherapy (HR 0.35) decreased tumor recurrence, while adjuvant chemotherapy had no effect. Lin PH. J Surg Oncol 2013; 108(6): 352
![Page 62: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/62.jpg)
Your 52 yr old patient treated for HR+ EBC and now on Exemestrane says she is in the pink of
health with no musculoskeletal symptoms, vasomotor or vulvovaginal symptoms.
Inference on her survival--A. She likely to have a decreased survivalB. No inference can be drawnC. She has same survival as for her stage of
cancerD. She is likely to have a better survival
![Page 63: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/63.jpg)
Your 52 yr old patient treated for HR+ EBC and now on Exemestrane says she is in the pink of
health with no musculoskeletal symptoms, vasomotor or vulvovaginal symptoms.
Inference on her survival--A. She likely to have a decreased survivalB. No inference can be drawnC. She has same survival as for her stage of cancerD. She is likely to have a better survival
Fontein DB et al. JCO 2013; 31(18): 2257-64International Tamoxifen Exemestrane Multinational Trial
![Page 64: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/64.jpg)
The drugs recommended for breast cancer risk reduction in a 50yr old
postmenopausal lady with family history of breast cancer and dense breasts are
A. Raloxifene or TamoxifenB. Raloxifene onlyC. Raloxifene, Tamoxifen and Exemestrane
![Page 65: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/65.jpg)
The drugs recommended for breast cancer risk reduction in a 50yr old
postmenopausal lady with family history of breast cancer and dense breasts are
A. Raloxifene or TamoxifenB. Raloxifene onlyC. Raloxifene, Tamoxifen and Exemestrane
Moyer VA, et al. Ann Intern Med. 2013 Sep 24. USPSTF recommendations
![Page 66: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/66.jpg)
Attachment of H Pylori to the gastric epithelium leads to activation of NF-Kb
and increased A. IL-8B. VEGFC. MMP-2D. HGF
![Page 67: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/67.jpg)
Attachment of H Pylori to the gastric epithelium leads to activation of NF-Kb
and increased A. IL-8B. VEGFC. MMP-2D. HGF
![Page 68: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/68.jpg)
Use of S-1 a novel drug based on 5FU with Cisplatin compared to the standard Cisplatin + 5FU for
gastric cancer reveals
A. Cis plat + S-1 is more effectiveB. Increased incidence of Stomatitis, Febrile
neutropeniaC. Lower incidence of hand foot syndromeD. Increased treatment related deaths
![Page 69: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/69.jpg)
Use of S-1 a novel drug based on 5FU with Cisplatin compared to the standard Cisplatin + 5FU for
gastric cancer reveals
A. Cis plat + S-1 is more effectiveB. Increased incidence of Stomatitis, Febrile
neutropeniaC. Lower incidence of hand foot syndromeD. Increased treatment related deaths
Ajani JA et al. Eur J Cancer 2013; 49(17):3616-24. CS is noninferior to CF and has improved safety
![Page 70: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/70.jpg)
What is not true for follow up of Stage II and III Colon Cancer
A. 80% recurrences occur in the first 2-2.5 yrsB. CT abdomen and chest recommended
annually for 3 yrsC. If surveillance colonoscopy is fine at 1 yr
colonoscopy is done every 2 yrsD. PET scan can be recommended as part of a
trial only
![Page 71: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/71.jpg)
What is not true for follow up of Stage II and III Colon Cancer
A. 80% recurrences occur in the first 2-2.5 yrsB. CT abdomen and chest recommended
annually for 3 yrsC. If surveillance colonoscopy is fine at 1 yr
colonoscopy is done every 2 yrsD. PET scan can be recommended as part of a
trial onlyASCO endorsed the guideline prepared by CCO ( JCO Nov 2012 )
![Page 72: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/72.jpg)
Incorrect about carcinoid tumours
A. Causes depletion of tyrosineB. Some patients may have dermatological
manifestations in sun exposed partsC. 10% secrete excessive levels of SerotoninD. May produce tricuspid stenosis
![Page 73: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/73.jpg)
Incorrect about carcinoid tumours
A. Causes depletion of tyrosine. The aminoacid depleted is tryptophan
B. Some patients may have dermatological manifestations in sun exposed parts
C. 10% secrete excessive levels of SerotoninD. May produce tricuspid stenosis
![Page 74: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/74.jpg)
This computer scientist and professor at Carnagie Mellon University was an author
of a best seller called
A. Alice projectB. Time managementC. Achieving your
childhood dreamsD. The last lecture
![Page 75: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/75.jpg)
This computer scientist and professor at Carnagie Mellon University was an author
of a best seller called
A. Alice projectB. Time managementC. Achieving your
childhood dreamsD.The last lecture by
Randy Pausch
![Page 76: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/76.jpg)
The 5 year survival of stage 1 pancreatic cancer is--
A. Less than 30%B. 50%C. 65%D. 5%
![Page 77: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/77.jpg)
The 5 year survival of stage 1 pancreatic cancer is--
A. Less than 30%B. 50%C. 65%D. 5%
![Page 78: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/78.jpg)
In patients with nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs), when
preoperative grading assessment is not achieved, which clinical variable is an excellent predictor of post-treatment nodal positivity?
A. Radiological tumour sizeB. BMIC. AgeD. Gender
![Page 79: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/79.jpg)
In patients with nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs), when
preoperative grading assessment is not achieved, which clinical variable is an excellent predictor of post-treatment nodal positivity?
A. Radiological tumour sizeB. BMIC. AgeD. Gender
Partelli S, et al. JAMA Surg. 2013;148(10):932-939.
![Page 80: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/80.jpg)
In patients with hepatocellular carcinoma (HCC) receiving transarterial
therapy (TACE/TAE), which is NOT a prognostic factor for risk of death?
A. Albumin > 3.6 g/dlB. Bilirubin > 17umol/lC. Tumour Size > 7 cmD. AFP >400ng/dl
![Page 81: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/81.jpg)
In patients with hepatocellular carcinoma (HCC) receiving transarterial
therapy (TACE/TAE), which is NOT a prognostic factor for risk of death?
A. Albumin > 3.6 g/dlB. Bilirubin > 17umol/lC. Tumour Size > 7 cmD. AFP >400ng/dl
This is the hepatoma arterial embolization prognostic score. Kadalayil L, et al. Ann Oncol. 2013;24(10):2565-2570.
![Page 82: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/82.jpg)
For adult survivors of childhood cancer, which organ system is the most at-risk for disease
during adulthood after exposure to treatment with potential toxicity?
A. PulmonaryB. HaematopoieticC. HepaticD. Gastrointestinal
.
![Page 83: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/83.jpg)
For adult survivors of childhood cancer, which organ system is the most at-risk for disease
during adulthood after exposure to treatment with potential toxicity?
A. PulmonaryB. HaematopoieticC. HepaticD. Gastrointestinal
Less than 15% develop haematopoietic, hepatic, skeletal dysfunction. Other organs at risk are cardiac, neurologic, neurocognitive and endocrine.
Hudson MM, et al. JAMA. 2013;309(22):2371-2381.
![Page 84: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/84.jpg)
What percentage of adult survivors of childhood cancer develop an adult
neoplasm (benign and or malignant)
A. 16%B. 45%C. 3%D. 0.5%
![Page 85: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/85.jpg)
What percentage of adult survivors of childhood cancer develop an adult
neoplasm (benign and or malignant)
A. 16%B. 45%C. 3%D. 0.5%Hudson MM, et al. JAMA. 2013;309(22):2371-2381.
![Page 86: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/86.jpg)
This actor was diagnosed with ---- in the film
A. LeukaemiaB. Brain TumourC. Lymphosarcoma
of Intestine
![Page 87: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/87.jpg)
Risk of recurrence in GIST after surgery is high (55% or more)in all except:
A. More than 10 cm size in any locationB. 2-5cm with mitosis 5 per 50HPFC. Mucosal invasionD. Mitosis >1 per 5HPF
![Page 88: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/88.jpg)
Risk of recurrence in GIST after surgery is high (55% or more)in all except:
A. More than 10 cm size in any locationB. 2-5cm with mitosis 5 per 50HPFC. Mucosal invasionD. Mitosis >1 per 5HPF
![Page 89: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/89.jpg)
Most of the GIST are positive for CD117. Approximately 8% are CD117 negative but PDGFRA positive. These tumours
are-A. Clinically indolent, located in small intestineB. Clinically aggressive, located in stomach andC. Clinically indolent, located in stomach,
![Page 90: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/90.jpg)
Most of the GIST are positive for CD117. Approximately 8% are CD117 negative but PDGFRA positive. These tumours
are-A. Clinically indolent, located in small intestineB. Clinically aggressive, located in stomach andC. Clinically indolent, located in stomach Haematology Oncology Clinics: Rare Cancers. Dec 2012.
These PDGFRA positive tumours commonly are of epithelioid morphology and the commonest mutation is on exon 18 (D842V) which makes them resistant to TKI
![Page 91: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/91.jpg)
The expected DFS following non operative management of clinical CR of Stage I-III rectal cancer treated by
neoadjuvant CCRT is
A. 50%B. 80%C. 60%D. 40%
![Page 92: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/92.jpg)
The expected DFS following non operative management of clinical CR of Stage I-III rectal cancer treated by
neoadjuvant CCRT is
A. 50%B. 80%C. 60%D. 40%Solanki AA et al. Onco Targets and therapy 2013; 2013(6): 1097-1110
![Page 93: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/93.jpg)
Who is this surgeon
A.Frank H. NetterB.B FisherC.CW Lilliehei
![Page 94: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/94.jpg)
Who is this surgeon
A. Frank H. Netter was an American surgeon and celebrated medical illustrator. The first edition of his Atlas of Human Anatomy — his "personal Sistine Chapel" — was published in 1989 and he was made a Fellow of the New York Academy of Medicine
B. B FisherC. CW Lilliehei
![Page 95: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/95.jpg)
Statistics: the incorrect statement is
A. Type 1 error is fixed aprioriB. Increasing sample size has no effect on type 2
errorC. Doubling sample size does not affect
confidence intervalD. Sample size and effect size are inversely
related
![Page 96: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/96.jpg)
Statistics: the incorrect statement is
A. Type 1 error is fixed aprioriB. Increasing sample size has no effect on type
2 errorC. Doubling sample size does not affect
confidence intervalD. Sample size and effect size are inversely
related
![Page 97: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/97.jpg)
Which is not a subtypes of Chondroma
A. EctochondromaB. EnchondromaC. Perosteal chondromaD. Soft tissue Chondroma
![Page 98: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/98.jpg)
Which is not a subtypes of Chondroma
A. EctochondromaB. EnchondromaC. Perosteal chondromaD. Soft tissue Chondroma
![Page 99: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/99.jpg)
What minimum dose of radiation is needed to produce a statistically superior response to bone pain
A. 10 GyB. 8 GyC. 15 GyD. 4 Gy
![Page 100: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/100.jpg)
What minimum dose of radiation is needed to produce a statistically superior response to bone pain
A. 10 GyB. 8 GyC. 15 GyD. 4 Gy
Dennis K. Radiother Oncol 2013; 106(1) 5-14In this systematic analysis the authors found that the minimum dose of 8Gy was needed to reduce pain in bone mets.
![Page 101: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/101.jpg)
Most common Uterine Sarcoma
A. CarcinosarcomaB. Endometrial stromal sarcomaC. LeiomyosarcomaD. Adenosarcoma
![Page 102: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/102.jpg)
Most common Uterine Sarcoma
A. CarcinosarcomaB. Endometrial stromal sarcomaC. LeiomyosarcomaD. Adenosarcoma
![Page 103: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/103.jpg)
He hypothesised the angiogenesis theory for cancer which states that a tumor is able to
create its own blood supply. Dozens of cancer drugs were developed based on his research.
A. Dr J Michael BishopB. Dr Harold E VarmusC. Dr Judah FolkmanD. Dr Brian J Druker
![Page 104: Oncology Quiz with answers](https://reader033.vdocuments.net/reader033/viewer/2022050804/547de101b4af9fb16b8b462d/html5/thumbnails/104.jpg)
He hypothesised the angiogenesis theory for cancer which states that a tumor is able to
create its own blood supply. Dozens of cancer drugs were developed based on his research.
A. Dr J Michael BishopB. Dr Harold E Varmus
Nobel for Oncogene 1989
C. Dr Judah FolkmanD. Dr Brian J Druker
Along with Nicholas B. Lydon and Charles Sawyers, Lasker for CML